Beta-blockers in non-obstructive hypertrophic cardiomyopathy: time to ease the heart rate restriction?

Eur Heart J. 2023 Oct 1;44(37):3655-3657. doi: 10.1093/eurheartj/ehad518.

Authors

Adaya Weissler-Snir^{1

2}, Harry Rakowski³, Markus Meyer⁴

Affiliations

¹ Hartford HealthCare, Heart and Vascular Institute, 80 Seymour St, Hartford, CT 06106, USA.
² Department of Medicine, University of Connecticut Farmington, CT, USA.
³ The Division of Cardiology, Peter Munk Cardiac Centre, University Health Network, Toronto General Hospital, 585 University Ave, Toronto, ON M5G 2N2, Canada.
⁴ Lillehei Heart Institute, Department of Medicine, University of Minnesota, 2231 6th Street SE, Minneapolis, MN 55455, USA.

PMID: 37650505
DOI: 10.1093/eurheartj/ehad518

No abstract available

MeSH terms

Adrenergic beta-Antagonists / therapeutic use
Cardiomyopathy, Hypertrophic* / drug therapy
Heart Rate
Humans

Substances

Adrenergic beta-Antagonists